These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Preharvest application of methyl jasmonate increases crop yield, fruit quality and bioactive compounds in pomegranate 'Mollar de Elche' at harvest and during postharvest storage.
    Author: García-Pastor ME, Serrano M, Guillén F, Giménez MJ, Martínez-Romero D, Valero D, Zapata PJ.
    Journal: J Sci Food Agric; 2020 Jan 15; 100(1):145-153. PubMed ID: 31471914.
    Abstract:
    BACKGROUND: Previous reports have addressed the effectiveness of postharvest methyl jasmonate (MeJA) treatments on maintaining quality properties of pomegranate fruit during storage. However, there is no literature regarding the effects of preharvest MeJA treatments on pomegranate 'Mollar de Elche' crop yield, fruit ripening, quality attributes and bioactive compounds content (at harvest or after long-term storage), which were evaluated in this research. RESULTS: Preharvest MeJA treatments (1, 5, and 10 mmol L-1 ) increased pomegranate crop yield. MeJA at 1 and 5 mmol L-1 accelerated the on-tree ripening process, while it was delayed with 10 mmol L-1 . Losses in fruit weight, firmness and organic acids during storage at 10 °C were delayed in MeJA treated fruit, leading to quality maintenance. In addition, MeJA treatments improved arils colour due to increased concentration of total and individual anthocyanins, at harvest and during storage. Total phenolic and ascorbic acid contents and total antioxidant activity [hydrophilic (H-TAA) and lipophilic (L-TAA) fractions] were also higher in arils from treated pomegranate fruits than in controls. CONCLUSION: Preharvest treatments with MeJA could be a promising tool to improve pomegranate crop yield, fruit quality and its content in bioactive compounds at harvest and during storage. The higher effects were obtained with MeJA at 5 mmol L-1 dose, which could be the selected treatment for practical application purposes. © 2019 Society of Chemical Industry.
    [Abstract] [Full Text] [Related] [New Search]